Literature DB >> 21956518

Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options.

Satoru Suzuki1, Satoshi Shigematsu, Hidefumi Inaba, Masahiro Takei, Teiji Takeda, Mitsuhisa Komatsu.   

Abstract

Thyroid hormone secretion suppresses the expression of thyroid stimulating hormone (TSH), both of which are strictly controlled by a negative feedback loop between the hypothalamus-pituitary and thyroid. Pituitary resistance to thyroid hormone (PRTH) is defined as resistance to the action of thyroid hormone that is more severe in the pituitary than at the peripheral tissue level. Although the molecular basis of PRTH is not well understood, the clinical issue mainly involves imbalance between the hypothalamus-pituitary and peripheral thyroid hormone responsivity, which may induce peripheral thyrotoxic phenomena. Here, we review the pathogenesis and molecular aspects of PRTH, present a single case with inappropriate TSH secretion suffering from thyrotoxicosis treated with PTU, and discuss the possible choice of therapeutic options to correct the imbalance of thyroid hormone responsivity in both the hypothalamus-pituitary and peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956518     DOI: 10.1007/s12020-011-9538-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  35 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Hypothalamic dorsomedial nucleus neurons innervate thyrotropin-releasing hormone-synthesizing neurons in the paraventricular nucleus.

Authors:  E Mihály; C Fekete; G Légrádi; R M Lechan
Journal:  Brain Res       Date:  2001-02-09       Impact factor: 3.252

3.  Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.

Authors:  M J Schneider; S N Fiering; S E Pallud; A F Parlow; D L St Germain; V A Galton
Journal:  Mol Endocrinol       Date:  2001-12

4.  9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).

Authors:  Tulay Guran; Serap Turan; Rlfat Bircan; Abdullah Bereket
Journal:  J Pediatr Endocrinol Metab       Date:  2009-10       Impact factor: 1.634

5.  Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".

Authors:  M C Gershengorn; B D Weintraub
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8.

Authors:  Marija Trajkovic; Theo J Visser; Jens Mittag; Sigrun Horn; Jan Lukas; Veerle M Darras; Genadij Raivich; Karl Bauer; Heike Heuer
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

Review 7.  Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism.

Authors:  Maria Izabel Chiamolera; Fredric E Wondisford
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 8.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

9.  Successful treatment of hyperthyroidism due to nonneoplastic pituitary TSH hypersecretion with 3,5,3'-triiodothyroacetic acid (TRIAC).

Authors:  P Beck-Peccoz; G Piscitelli; M G Cattaneo; G Faglia
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

10.  3,5,3'-triiodothyroacetic acid therapy for thyroid hormone resistance.

Authors:  J M Kunitake; N Hartman; L C Henson; J Lieberman; D E Williams; M Wong; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1989-08       Impact factor: 5.958

View more
  3 in total

1.  Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders.

Authors:  Joseph Alvin R Santos; Anthea Christoforou; Kathy Trieu; Briar L McKenzie; Shauna Downs; Laurent Billot; Jacqui Webster; Mu Li
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

2.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30

3.  Small-molecule hormones: molecular mechanisms of action.

Authors:  Monika Puzianowska-Kuznicka; Eliza Pawlik-Pachucka; Magdalena Owczarz; Monika Budzińska; Jacek Polosak
Journal:  Int J Endocrinol       Date:  2013-02-28       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.